In that small cohort of patients (n = 21), all responding patients had tumors with >80% of tumor cells expressing 2+/3+ CLDN6 at prescreening, suggesting that the CLDN6 expression level may be predictive of the outcome. The gene discussed is CLDN6; the disease is neoplasm.